Biovest emerges from bankruptcy again; Sabin begins vaccine discovery program;

> Biovest has emerged from bankruptcy for the second time and named a new CEO. News

> The Sabin Vaccine Institute has begun a soil-transmitted helminth vaccine discovery program. Release

> WHO believes a vaccine for malaria could be available in the next three years. Article

> Bulgaria is facing a shortage of childhood vaccines because a former manager failed to order the shots. Piece

> The outgoing Iranian president has inaugurated the country's first flu vaccine production line. Item

> Baxter ($BAX) and other developers of Lyme disease vaccines face scepticism from advocacy groups. Feature

> India has procured yellow fever vaccines from Sanofi ($SNY) to overcome the recent shortage. News

And Finally... Canada's NCIC Clinical Trials Group is to sponsor a Phase II study of Immunovaccine's cancer vaccine. Release

Virtual Clinical Trials Summit

Virtual Clinical Trials Summit: The Premier Educational Event Focused on Decentralized Clinical Trials

In this virtual environment, we will look at current and future trends for ongoing virtual trials, diving into the many ways companies can improve patient engagement and trial behavior to enhance retention with a focus on emerging technology and harmonized data access across the clinical trial system.